参考文献/References:
1 Cook GJ, Wegner EA, Fogelman I, et al. Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imaging. Semin Nucl Med, 2004,34(2):122-133.
2 Avril N. Glutl expression in tissue and 18F-FDG uptake. J Nucl Med, 2004, 45(6):930-932.
3 Guitart X, Codony X, Monroy X. Sigma receptors:biology and therapeutic potential. Psychopharmacology, 2004, 174(3):301-319.
4 Bern WT, Thomas GE, Mamone JY, et al. Overexpression of σ receptors in nonneural human tumors. Cancer Res, 1991, 51(24):6558-6562.
5 Vilner BJ, John CS, Bowen WD. Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines.Cancer Res, 1995, 55(2):408-413.
6 Bowen WD. Sigma receptors:recent advances and new clinical potentials. Pharm Acta Helv, 2000, 74(2):211-218.
7 Aydar E, Palmer CP, Djamgoz MB. Sigma receptor and cancer:possible involvement of ion channels. Cancer Res, 2004, 64(15):5029-5035.
8 Caveliers V, Everaert H, Lahoutte T, et al. labelled sigma receptor ligands:can their role in neurology and oncology be extended?.Eur J Nucl Med, 2001, 28(2):133-135.
9 Caveliers V, Everaert H, John CS, et al. Sigma receptor scintigraphy with N-[2-(1’-piperidinyl)ethyl]-3-^123iodo-4-methoxybenzamide of patients with suspected primary breast cancer:first clinical results.J Nucl Med, 2002, 43(12):1647-1649.
10 Choi SR, Yang B, Plossl K, et al. Development of a Tc-99m labeled sigma-2 receptor-specific ligand as a potential breast tumor imaging agent. Nucl Med Biol, 2001, 28(6):657-666.
11 Mach RH, Huang Y, Buchheimer N, et al.[18F] N-4’-fluorbenzyl-4-(3-bromophenyl) acetamide for imaging the sigma receptor status of tumors:comparison with[18F]FDG and[125I]IUDR. Nucl Med Biol, 2001, 28(4):451-458.
12 John CS, Vilner B J, Geyer BC, et al. Targeting sigma receptor-binding benzamides as in vivo diagnostic and therapeutic agents for human prostate tumors. Cancer Res, 1999, 59(18):4578-4583.
13 Moody TW, Leyton J, John C. Sigma ligand inhibit the growth of small cell lung cancer cells. Life Sci, 2000, 66(20):1979-1986.
14 Mach RH, Huang Y, Freeman RA, et al. Conformationally-flexible benzamide analogues as dopamine D3 and Sigma2 receptor ligands.Bioorg Med Chem Lett, 2004, 14(1):195-202.
相似文献/References:
[1]何燕,苏晋,郑晓霞,等.P-糖蛋白抑制剂在PET显像中的应用研究[J].国际放射医学核医学杂志,2016,40(1):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
He Yan,Su Jin,ZhengXiaoxia,et al.Developing P-glycoprotein inhibitor marked by PET[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
[2]许飞,刘建军,黄钢,等.PET乏氧显像在预测肿瘤乏氧及指导临床治疗中的应用进展[J].国际放射医学核医学杂志,2016,40(1):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
Xu Fei,Liu Jianjun,Huang Gang,et al.The application of hypoxia imaging with PET in predicting tumor hypoxia and guiding clinical therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
[3]陈顺军,程兵.肿瘤细胞凋亡核素显像分子探针研究进展[J].国际放射医学核医学杂志,2016,40(2):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
Chen Shunjun,Cheng Bing.Progress in molecular probes of radionuclide tumor apoptosis imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
[4]陈晓艳,张江虹,邵春林.STAT3与辐射敏感相关性的研究进展[J].国际放射医学核医学杂志,2016,40(3):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
Chen Xiaoyan,Jianghong,Shao Chunlin.Research progresses of correlation between STAT3 and radiosensitivity[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
[5]赵舒怡,储小飞,樊赛军.血清肿瘤标志物与肿瘤放疗疗效评估的研究进展[J].国际放射医学核医学杂志,2015,39(5):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
zhao shuyi,chu xiaofei,fan saijun..progression of study on serum tumor markers in evaluation of tumor radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(3):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
[6]赵徵鑫,翟贺争,张文艺,等.质子重离子治疗肿瘤的进展[J].国际放射医学核医学杂志,2016,40(5):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
Zhao Zhixin,Zhai Hezheng,Zhang Wenyi,et al.Development of proton heavy ion in tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
[7]任佳忠,李永梅,刘岩,等.99Tcm-MDP骨显像胸部异常放射性摄取的原因分析[J].国际放射医学核医学杂志,2016,40(6):459.[doi:10.3760/cma.j.issn.1673-4114.2016.06.011]
Jiazhong,Li Yongmei,Liu Yan,et al.Reasons for the abnormal 99Tcm-MDP uptake in the thoracic tissue on bone scintigraphy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):459.[doi:10.3760/cma.j.issn.1673-4114.2016.06.011]
[8]马彦云,张辉.磁共振体素内不相干运动扩散加权成像的原理及应用进展[J].国际放射医学核医学杂志,2016,40(6):469.[doi:10.3760/cma.j.issn.1673-4114.2016.06.013]
Ma Yanyun,Zhang Hui.The basic principle and application progress of intravoxel incoherent motion imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(3):469.[doi:10.3760/cma.j.issn.1673-4114.2016.06.013]
[9]杨卫东,汪静.肿瘤核素靶向治疗新进展[J].国际放射医学核医学杂志,2015,39(1):19.[doi:10.3760/cma.j.issn.1673-4114.2015.01.006]
Yang Weidong,Wang Jing.Advance progress of radionuclide target tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(3):19.[doi:10.3760/cma.j.issn.1673-4114.2015.01.006]
[10]徐金苹,袁德晓,张江虹,等.辐射诱导的外泌体在肿瘤细胞侵袭转移中的作用[J].国际放射医学核医学杂志,2015,39(2):144.[doi:10.3760/cma.j.issn.1673-4114.2015.02.009]
Xu Jinping,Yuan Dexiao,Zhang Jianghong,et al.The role of radiation-induced exosomes in tumor invasion and metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(3):144.[doi:10.3760/cma.j.issn.1673-4114.2015.02.009]